{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:14:48Z","timestamp":1768288488329,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,6]]},"DOI":"10.7759\/cureus.73112","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:26:42Z","timestamp":1730892402000},"source":"Crossref","is-referenced-by-count":1,"title":["Thrombocytosis and Thrombocytopenia in Treatment-Na\u00efve Rheumatoid Arthritis Patients: A Single-Centre Retrospective Data-Based Study From Pakistan"],"prefix":"10.7759","author":[{"given":"Nauman Ismat","family":"Butt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Sohail Ajmal","family":"Ghoauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barak","family":"Waris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Umair","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dure","family":"Sabeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Qaisar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/life12010077","article-title":"COVID-19-a trigger factor for severe immune-mediated thrombocytopenia in active rheumatoid arthritis","volume":"12","author":"Bobirc\u0103 A","year":"2022","unstructured":"Bobirc\u0103 A, Bobirc\u0103 F, Ancu\u021ba I, et al.. COVID-19-a trigger factor for severe immune-mediated thrombocytopenia in active rheumatoid arthritis. Life (Basel). 2022, 12:77. 10.3390\/life12010077","journal-title":"Life (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5049.144643","article-title":"Overview of the coagulation system","volume":"58","author":"Palta S","year":"2014","unstructured":"Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014, 58:515-23. 10.4103\/0019-5049.144643","journal-title":"Indian J Anaesth"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019096","article-title":"Immature platelet fraction: a useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery","volume":"99","author":"Jeon K","year":"2020","unstructured":"Jeon K, Kim M, Lee J, Lee JS, Kim HS, Kang HJ, Lee YK. Immature platelet fraction: a useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery. Medicine (Baltimore). 2020, 99:e19096. 10.1097\/MD.0000000000019096","journal-title":"Medicine (Baltimore)"},{"key":"ref4","article-title":"Thrombocytopenia and its comparison with Plasmodium vivax and Plasmodium falciparum in malaria patients","volume":"2022","author":"Ajmal M","year":"2022","unstructured":"Ajmal M, Hassaan M, Butt NI, Aftab S, Ashfaq F, Bhatti AI. Thrombocytopenia and its comparison with Plasmodium vivax and Plasmodium falciparum in malaria patients. Pak J Med Res. 2022, 2022:140-4.","journal-title":"Pak J Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00880","article-title":"Emerging concepts in immune thrombocytopenia","volume":"9","author":"Swinkels M","year":"2018","unstructured":"Swinkels M, Rijkers M, Voorberg J, Vidarsson G, Leebeek FW, Jansen AJ. Emerging concepts in immune thrombocytopenia. Front Immunol. 2018, 9:880. 10.3389\/fimmu.2018.00880","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.35.2.138","article-title":"Thrombocytosis in rheumatoid arthritis","volume":"35","author":"Hutchinson RM","year":"1976","unstructured":"Hutchinson RM, Davis P, Jayson MI. Thrombocytosis in rheumatoid arthritis. Ann Rheum Dis. 1976, 35:138-42. 10.1136\/ard.35.2.138","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1747-0","article-title":"Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia","volume":"32","author":"Ayvaz OC","year":"2012","unstructured":"Ayvaz OC, Yavasoglu I, Kadikoylu G, Bozkurt G, Bolaman Z. Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia. Rheumatol Int. 2012, 32:269-71. 10.1007\/s00296-010-1747-0","journal-title":"Rheumatol Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.33545\/pathol.2019.v2.i2g.134","article-title":"Frequency of occurrence of haematological abnormalities among rheumatoid arthritis patients","volume":"2","author":"Tripathi S","year":"2019","unstructured":"Tripathi S, Verma M. Frequency of occurrence of haematological abnormalities among rheumatoid arthritis patients. Int J Clin Diagn Pathol. 2019, 2:405-7. 10.33545\/pathol.2019.v2.i2g.134","journal-title":"Int J Clin Diagn Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez343","article-title":"Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials","volume":"59","author":"Vanni KM","year":"2020","unstructured":"Vanni KM, Lyu H, Solomon DH. Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials. Rheumatology (Oxford). 2020, 59:709-17. 10.1093\/rheumatology\/kez343","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/030097402760375124","article-title":"Hematological manifestations of rheumatoid arthritis","volume":"31","author":"Bowman SJ","year":"2002","unstructured":"Bowman SJ. Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol. 2002, 31:251-9. 10.1080\/030097402760375124","journal-title":"Scand J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel204","article-title":"TNFalpha blocker-induced thrombocytopenia","volume":"45","author":"Pathare SK","year":"2006","unstructured":"Pathare SK, Heycock C, Hamilton J. TNFalpha blocker-induced thrombocytopenia. Rheumatology (Oxford). 2006, 45:1313-4. 10.1093\/rheumatology\/kel204","journal-title":"Rheumatology (Oxford)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2013.03.001","article-title":"Immune thrombocytopenia","volume":"27","author":"Kistangari G","year":"2013","unstructured":"Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am. 2013, 27:495-520. 10.1016\/j.hoc.2013.03.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3109\/s101650170013","article-title":"Immune thrombocytopenic purpura associated with rheumatoid arthritis - a report of five cases and review of the literature","volume":"11","author":"Ichikawa N","year":"2001","unstructured":"Ichikawa N, Harigai M, Nakajima A, Hara M, Kamatani N. Immune thrombocytopenic purpura associated with rheumatoid arthritis - a report of five cases and review of the literature. Mod Rheumatol. 2001, 11:246-50. 10.3109\/s101650170013","journal-title":"Mod Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes279","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51 Suppl 6","author":"Kay J","year":"2012","unstructured":"Kay J, Upchurch KS. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford). 2012, 51 Suppl 6:vi5-9. 10.1093\/rheumatology\/kes279","journal-title":"Rheumatology (Oxford)"},{"key":"ref15","article-title":"The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis","volume":"34","author":"van Riel PL","year":"2016","unstructured":"van Riel PL, Renskers L. The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol. 2016, 34:S40-4.","journal-title":"Clin Exp Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-3","article-title":"Essential thrombocythemia","volume":"2","author":"Bri\u00e8re JB","year":"2007","unstructured":"Bri\u00e8re JB. Essential thrombocythemia. Orphanet J Rare Dis. 2007, 2:3. 10.1186\/1750-1172-2-3","journal-title":"Orphanet J Rare Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: an updated international multi-centre cohort study","volume":"42","author":"Bernatsky S","year":"2013","unstructured":"Bernatsky S, Ramsey-Goldman R, Labrecque J, et al.. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun. 2013, 42:130-5. 10.1016\/j.jaut.2012.12.009","journal-title":"J Autoimmun"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-22-0323","article-title":"JAK: not just another kinase","volume":"21","author":"Agashe RP","year":"2022","unstructured":"Agashe RP, Lippman SM, Kurzrock R. JAK: not just another kinase. Mol Cancer Ther. 2022, 21:1757-64. 10.1158\/1535-7163.MCT-22-0323","journal-title":"Mol Cancer Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.344.15281","article-title":"An elusive case of digital ischemia in a patient with rheumatoid arthritis","volume":"34","author":"Azam W","year":"2018","unstructured":"Azam W, Erum U, Muhammad AJ. An elusive case of digital ischemia in a patient with rheumatoid arthritis. Pak J Med Sci. 2018, 34:1024-6. 10.12669\/pjms.344.15281","journal-title":"Pak J Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.51774","article-title":"Extra-articular manifestations of rheumatoid arthritis: a hospital-based study","volume":"29","author":"Al-Ghamdi A","year":"2009","unstructured":"Al-Ghamdi A, Attar SM. Extra-articular manifestations of rheumatoid arthritis: a hospital-based study. Ann Saudi Med. 2009, 29:189-93. 10.4103\/0256-4947.51774","journal-title":"Ann Saudi Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1185\/030079908x261177","article-title":"The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006","volume":"24","author":"Hochberg MC","year":"2008","unstructured":"Hochberg MC, Johnston SS, John AK. The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006. Curr Med Res Opin. 2008, 24:469-80. 10.1185\/030079908x261177","journal-title":"Curr Med Res Opin"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-024-00738-6","article-title":"Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use","volume":"25","author":"Honma T","year":"2024","unstructured":"Honma T, Onda K, Masuyama K. Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use. BMC Pharmacol Toxicol. 2024, 25:13. 10.1186\/s40360-024-00738-6","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.7.668","article-title":"Extra-articular rheumatoid arthritis: prevalence and mortality","volume":"38","author":"Turesson C","year":"1999","unstructured":"Turesson C, Jacobsson L, Bergstr\u00f6m U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford). 1999, 38:668-74. 10.1093\/rheumatology\/38.7.668","journal-title":"Rheumatology (Oxford)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.69656\/pjp.v19i4.1537","article-title":"Prevalence of carpal tunnel syndrome in patients with rheumatoid arthritis and its association with disease severity","volume":"19","author":"Butt NI","year":"2023","unstructured":"Butt NI, Rasheed MB, Ghoauri MSA, Khan FA, Ashfaq F, Anser A. Prevalence of carpal tunnel syndrome in patients with rheumatoid arthritis and its association with disease severity. Pak J Phsyiol. 2023, 19:32-5. 10.69656\/pjp.v19i4.1537","journal-title":"Pak J Phsyiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","author":"GBD 2021 Rheumatoid Arthritis Collaborators","year":"2023","unstructured":"GBD 2021 Rheumatoid Arthritis Collaborators. Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023, 5:e594-610. 10.1016\/S2665-9913(23)00211-4","journal-title":"Lancet Rheumatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2007.05.007","article-title":"Extra-articular manifestations and complications of rheumatoid arthritis","volume":"21","author":"Young A","year":"2007","unstructured":"Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007, 21:907-27. 10.1016\/j.berh.2007.05.007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/ar1886","article-title":"HLA-DRB1 genes and extraarticular rheumatoid arthritis","volume":"8","author":"Roudier J","year":"2006","unstructured":"Roudier J. HLA-DRB1 genes and extraarticular rheumatoid arthritis. Arthritis Res Ther. 2006, 8:103. 10.1186\/ar1886","journal-title":"Arthritis Res Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/315495-thrombocytosis-and-thrombocytopenia-in-treatment-nave-rheumatoid-arthritis-patients-a-single-centre-retrospective-data-based-study-from-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:26:43Z","timestamp":1730892403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/315495-thrombocytosis-and-thrombocytopenia-in-treatment-nave-rheumatoid-arthritis-patients-a-single-centre-retrospective-data-based-study-from-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.73112","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,6]]}}}